The Neuroprotection Effects of Exosome in Central Nervous System Injuries: a New Target for Therapeutic Intervention
- PMID: 36103108
- DOI: 10.1007/s12035-022-03028-6
The Neuroprotection Effects of Exosome in Central Nervous System Injuries: a New Target for Therapeutic Intervention
Abstract
Central nervous system (CNS) injuries, including traumatic brain injury (TBI), spinal cord injury (SCI), and subarachnoid hemorrhage (SAH), are the most common cause of death and disability around the world. As a key subset of extracellular vesicles (EVs), exosomes have recently attracted great attentions due to their functions in remodeling extracellular matrix and transmitting signals and molecules. A large number of studies have suggested that exosomes played an important role in brain development and involved in many neurological disorders, particularly in CNS injuries. It has been proposed that exosomes could improve cognition function, inhibit apoptosis, suppress inflammation, regulate autophagy, and protect blood brain barrier (BBB) in CNS injuries via different molecules and pathways including microRNA (miRNA), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), phosphatidylinositol-4,5-bisphosphate 3-kinase/protein kinase B (PI3K/AKT), Notch1, and extracellular regulated protein kinases (ERK). Therefore, exosomes showed great promise as potential targets in CNS injuries. In this article, we present a review highlighting the applications of exosomes in CNS injuries. Hence, on the basis of these properties and effects, exosomes may be developed as therapeutic agents for CNS injury patients.
Keywords: Central nervous system injuries; Downstream molecules; Exosomes.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Circular RNA in Acute Central Nervous System Injuries: A New Target for Therapeutic Intervention.Front Mol Neurosci. 2022 Mar 22;15:816182. doi: 10.3389/fnmol.2022.816182. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35392276 Free PMC article. Review.
-
Long Non-coding RNA in CNS Injuries: A New Target for Therapeutic Intervention.Mol Ther Nucleic Acids. 2019 Sep 6;17:754-766. doi: 10.1016/j.omtn.2019.07.013. Epub 2019 Jul 29. Mol Ther Nucleic Acids. 2019. PMID: 31437654 Free PMC article. Review.
-
FTY720 in CNS injuries: Molecular mechanisms and therapeutic potential.Brain Res Bull. 2020 Nov;164:75-82. doi: 10.1016/j.brainresbull.2020.08.013. Epub 2020 Aug 23. Brain Res Bull. 2020. PMID: 32846199 Review.
-
Crosstalk among N6-methyladenosine modification and RNAs in central nervous system injuries.Front Cell Neurosci. 2022 Sep 29;16:1013450. doi: 10.3389/fncel.2022.1013450. eCollection 2022. Front Cell Neurosci. 2022. PMID: 36246528 Free PMC article. Review.
-
Targeting Non-Coding RNA for CNS Injuries: Regulation of Blood-Brain Barrier Functions.Neurochem Res. 2023 Jul;48(7):1997-2016. doi: 10.1007/s11064-023-03892-1. Epub 2023 Feb 14. Neurochem Res. 2023. PMID: 36786944 Review.
Cited by
-
Mesenchymal stem cell-derived exosomes-a promising therapeutic approach to improve neurocognitive disorders in chronic obstructive pulmonary disease.Stem Cell Res Ther. 2025 Jun 20;16(1):314. doi: 10.1186/s13287-025-04457-5. Stem Cell Res Ther. 2025. PMID: 40542422 Free PMC article. Review.
-
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence.Mil Med Res. 2025 Feb 11;12(1):7. doi: 10.1186/s40779-025-00595-2. Mil Med Res. 2025. PMID: 39934876 Free PMC article. Review.
-
Harnessing the Stem Cell Niche in Regenerative Medicine: Innovative Avenue to Combat Neurodegenerative Diseases.Int J Mol Sci. 2024 Jan 12;25(2):993. doi: 10.3390/ijms25020993. Int J Mol Sci. 2024. PMID: 38256066 Free PMC article. Review.
-
Understanding the Antidepressant Mechanisms of Acupuncture: Targeting Hippocampal Neuroinflammation, Oxidative Stress, Neuroplasticity, and Apoptosis in CUMS Rats.Mol Neurobiol. 2025 Apr;62(4):4221-4236. doi: 10.1007/s12035-024-04550-5. Epub 2024 Oct 18. Mol Neurobiol. 2025. PMID: 39422855 Free PMC article.
-
Engineered exosomes enriched with select microRNAs amplify their therapeutic efficacy for traumatic brain injury and stroke.Front Cell Neurosci. 2024 Mar 19;18:1376601. doi: 10.3389/fncel.2024.1376601. eCollection 2024. Front Cell Neurosci. 2024. PMID: 38566841 Free PMC article. Review.
References
-
- Hornby TG, Reisman DS, Ward IG, Scheets PL, Miller A, Haddad D, Fox EJ, Fritz NE et al (2020) Clinical practice guideline to improve locomotor function following chronic stroke, incomplete spinal cord injury, and brain injury. J Neurol Phys Ther 44(1):49–100. https://doi.org/10.1097/NPT.0000000000000303 - DOI - PubMed
-
- Zhang L, Wang H (2019) Long non-coding RNA in CNS injuries: a new target for therapeutic intervention. Mol Ther Nucl Acids 17:754–766. https://doi.org/10.1016/j.omtn.2019.07.013 - DOI
-
- Devanney NA, Stewart AN, Gensel JC (2020) Microglia and macrophage metabolism in CNS injury and disease: the role of immunometabolism in neurodegeneration and neurotrauma. Exp Neurol 329:113310. https://doi.org/10.1016/j.expneurol.2020.113310 - DOI - PubMed - PMC
-
- Liddelow SA, Barres BA (2017) Reactive astrocytes: production, function, and therapeutic potential. Immunity 46(6):957–967. https://doi.org/10.1016/j.immuni.2017.06.006 - DOI - PubMed
-
- Hill AF (2019) Extracellular vesicles and neurodegenerative diseases. J Neurosci 39(47):9269–9273. https://doi.org/10.1523/JNEUROSCI.0147-18.2019 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous